Navigation Links
Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
Date:5/29/2008

WOODCLIFF LAKE, N.J., May 29 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that its development partner, Alfacell Corporation (Nasdaq: ACEL) reported that the preliminary statistical analysis of data from its confirmatory Phase IIIb clinical trial of its lead compound, ONCONASE (ranpirnase), did not meet statistical significance for the primary endpoint of survival in unresectable malignant mesothelioma (UMM). However, a statistically significant improvement in survival was seen in the treatment of UMM patients who failed one prior chemotherapy regimen.

The preliminary results are based on 320 evaluable events that occurred in the clinical trial out of a total of 428 patients randomized. The trial was designed to show a statistically significant improvement in overall survival (p < 0.048) for UMM patients who were treated with a combination of ONCONASE plus doxorubicin as compared to patients who were treated with doxorubicin as a single agent. The analysis of the data did not show a statistically significant improvement for evaluable patients receiving ONCONASE plus doxorubicin (unadjusted log rank p=0.80). The median survival time (MST) for evaluable patients who received ONCONASE plus doxorubicin was 11.1 months as compared to 10.7 months for patients who received doxorubicin as a single agent.

Statistically significant results were achieved in evaluable UMM patients who failed a prior chemotherapy
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
2. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
3. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
6. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
7. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
10. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
11. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 A six-hour certification program on ... presented at the Cannabis World Congress & Business Exposition ... York, NY .  Taking place on Wednesday, June 17 ... of education at the leading event on the East Coast ... Led by Clover Leaf University, the first cannabis university to ...
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hgs483/cardiovascular ) ... report "Cardiovascular Drug Delivery - Technologies, Markets ... Drug delivery to the cardiovascular system is different ... anatomy and physiology of the vascular system; it ... the body. Drugs can be introduced into the ...
(Date:5/29/2015)... Research and Markets ( ... "Surgical/Operating Microscopes Market by Application & End ... to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... poised to reach $806.6 million by 2020 from ... 12.3% from 2015 to 2020. , ,Major factors ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... BD (Becton, Dickinson and Company) (NYSE: BDX ... revenues of $2.051 billion for the fourth fiscal quarter ended ... the prior-year period, or 4.0 percent on a foreign currency-neutral ... September 30, 2011, BD reported revenues of $7.829 billion, representing ...
... NEW YORK, Nov. 1, 2011 Keryx Biopharmaceuticals, Inc. ... on the acquisition, development and commercialization of medically important ... disease, today announced that a conference call will be ... EDT to discuss results for the third quarter ended ...
Cached Medicine Technology:BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 2BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 3BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 4BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 5BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 6BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 7BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 8BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 9BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 10BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 11BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 12BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 13Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results 2
(Date:5/29/2015)... 29, 2015 The science of hair ... Angeles thanks to the efforts of internationally recognized hair ... combined ARTAS hair restoration and manual FUE ... procedures available anywhere. , A Follicular Unit Extraction ... harvesting hair follicle grafts from the donor areas of ...
(Date:5/29/2015)... CO (PRWEB) May 29, 2015 ... new addiction, substance abuse, and co-occurring mental health ... and ribbon cutting for the general public on ... 2nd. , The Recovery Village at Palmer Lake ... intensive outpatient programming, utilizing traditional and evidence-based therapies, ...
(Date:5/29/2015)... 29, 2015 Red Hot & Blue ... Red Hot & Blue restaurant at 525 New Waverly Place ... 7, 2015. “The Red Hot & Blue Restaurant was previously ... but we have moved to a new location in the ... middle of all the activities on the Promenade–with outdoor seating ...
(Date:5/29/2015)... 2015 A group of doctors have discovered ... national effort to teach this “new math” to children in ... been “sickened” by the recent implementation of Common Core Math ... it, Common Core is now a reality in children’s classrooms ... are now seeking ways to improve common core math training ...
(Date:5/29/2015)... has joined forces with Raw Elements Physical Eco Protection ... sun protection. The print component of “Skin Health” is ... 250,000 copies and an estimated readership of 750,000 readers. ... social media strategy, and across a network of top ... version of the campaign, click here . ...
Breaking Medicine News(10 mins):Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Doctors Discover a Cure for the Common Core 2
... advanced colorectal neoplasms was lower in participants in a ... received a colonoscopy in the preceding 10 years, according ... the Journal of the National Cancer Institute . ... been studied, but evidence from community settings is sparse, ...
... untreated, plantar fasciitis can lead to other problems, doctor says ... injuries" may bring to mind tennis elbow and jogger,s knee, ... of injury due to overuse, doctors warn. , The condition, ... of the foot, can become chronic if steps aren,t taken ...
... in otherwise healthy nonsmoking adults, study finds , WEDNESDAY, ... smokers face a higher risk of early emphysema when ... totally recovered from secondhand smoke exposure, new research suggests. ... scans on 1,781 non-smokers from six communities in the ...
... , WASHINGTON, Dec. 30 BIO Ventures for ... Chief Executive Officer of the global health non-profit. Moree has ... July 2009 and has been a member of the board of ... for Global Health as interim CEO, she served as Executive Director ...
... although legal, and adults use it widely to perk themselves ... But how strong is caffeine,s appeal in ... What impact does acute and chronic caffeine consumption have on ... does consuming caffeinated drinks during adolescence contribute to later use ...
... one day take potent therapies, get heart fixed later, researchers ... types of chemotherapy can damage the heart while thwarting cancer, ... new study in rats finds that injecting the heart with ... anti-cancer drug. , , The findings could one day mean ...
Cached Medicine News:Health News:Fewer left-sided colorectal tumors observed after colonoscopies 2Health News:Heel Pain Usually Relieved With Stretching Regimen 2Health News:BIO Ventures for Global Health Announces New CEO 2Health News:BIO Ventures for Global Health Announces New CEO 3Health News:Addictive effects of caffeine on kids being studied by UB neurobiologist 2Health News:Addictive effects of caffeine on kids being studied by UB neurobiologist 3Health News:Stem Cells Might Reverse Heart Damage From Chemo 2Health News:Stem Cells Might Reverse Heart Damage From Chemo 3
... bacterial growth system, combines orbital shaking, ... format for bacterial growth. It is ... HT-Prep™ Automatic DNA Extractor. The uniquely ... traditional floor shakers. Plate-holding cassettes allow ...
Inquire...
Inquire...
... refrigerated incubators that are ideal ... cycle,testing. Microprocessor controlled heating and ... High/low audible and visual alarms ... chamber safety thermostat,provides over-temperature protection.,Manual ...
Medicine Products: